Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review

Int J Rheum Dis. 2017 Nov;20(11):1823-1826. doi: 10.1111/1756-185X.12731. Epub 2015 Sep 10.

Authors

Yu-Jeong Oh¹, Won-Seok Lee¹, Wan-Hee Yoo¹, Jong-Ryeal Hahm², Hyun-Ok Kim³, Young Sun Suh³, Sang-Il Lee³, Yun-Hong Cheon³

Affiliations

¹ Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School of Chonbuk National Unversity, Jeonju, Korea.
² Divison of Endocrinology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.
³ Divison of Rheumatology, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.

PMID: 26355497
DOI: 10.1111/1756-185X.12731

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use
Biomarkers, Tumor / blood
Bromocriptine / therapeutic use
Dopamine Agonists / therapeutic use
Female
Humans
Magnetic Resonance Imaging
Pituitary Neoplasms / blood
Pituitary Neoplasms / diagnostic imaging
Pituitary Neoplasms / drug therapy
Pituitary Neoplasms / etiology*
Prolactin / blood
Prolactinoma / blood
Prolactinoma / diagnostic imaging
Prolactinoma / drug therapy
Prolactinoma / etiology*
Sjogren's Syndrome / blood
Sjogren's Syndrome / complications*
Sjogren's Syndrome / diagnosis
Sjogren's Syndrome / drug therapy
Treatment Outcome
Young Adult

Substances

Antineoplastic Agents, Hormonal
Biomarkers, Tumor
Dopamine Agonists
Bromocriptine
Prolactin